Mylan Agrees $465 Million Settlement in EpiPen Case

Global pharmaceuticals company Mylan has agreed to pay $465 million to settle EpiPen Medicaid claims against it over allegations that it overpriced its emergency allergy products. The settlement with the Department of Justice was announced by the drug maker on Friday. It comes after American lawmakers and federal health officials complained that Mylan had classified […]